The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Aug. 09, 2016
Filed:
Mar. 06, 2014
Carbohydrate profile compositions from human cells and methods for analysis and modification thereof
Applicant:
Glykos Finland Oy, Helsinki, FI;
Inventors:
Tero Satomaa, Helsinki, FI;
Jari Natunen, Vantaa, FI;
Jarmo Laine, Helsinki, FI;
Annamari Heiskanen, Helsinki, FI;
Maria Blomqvist, Itäsalmi, FI;
Anne Olonen, Lahti, FI;
Juhani Saarinen, Helsinki, FI;
Taina Jaatinen, Helsinki, FI;
Ulla Impola, Helsinki, FI;
Milla Mikkola, Helsinki, FI;
Heidi Anderson, Helsinki, FI;
Assignee:
GLYKOS FINLAND OY, Helsinki, FI;
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C12N 5/074 (2010.01); C12N 5/077 (2010.01); C12N 5/0775 (2010.01); C08B 37/00 (2006.01); G01N 33/569 (2006.01); G01N 33/574 (2006.01); G01N 33/577 (2006.01);
U.S. Cl.
CPC ...
C12N 5/0675 (2013.01); C08B 37/00 (2013.01); C12N 5/0662 (2013.01); C12N 5/0663 (2013.01); C12N 5/0664 (2013.01); C12N 5/0665 (2013.01); C12N 5/0666 (2013.01); C12N 5/0667 (2013.01); C12N 5/0668 (2013.01); G01N 33/56966 (2013.01); G01N 33/574 (2013.01); G01N 33/577 (2013.01); G01N 33/57469 (2013.01); C12N 2501/59 (2013.01); G01N 2400/10 (2013.01); G01N 2400/38 (2013.01); G01N 2560/00 (2013.01);
Abstract
The invention describes methods for production of novel composition of glycans, glycomes, from human multipotent stem cells. The invention is further directed to methods for modifying the glycomes and analysis of the glycomes and the modified glycomes. Furthermore the invention is directed to stem cells carrying the modified glycomes on their surfaces.